Form 4: Prothena Corp Public Ltd Executive Reports Stock Transaction

Sentiment:

Insider Transaction (Form 4)


Wagner M. Zago, Chief Scientific Officer of Prothena Corp Public Ltd Co, reported multiple transactions in common stock on July 28, 2026.

Summary

  • Option exercise/conversion: acquired 51,000 Ordinary Shares, par value $0.01 per share on July 28, 2026; holds 85,000 after (Direct).
  • Disposition to the issuer: disposed of 51,000 Ordinary Shares, par value $0.01 per share at $8.56 ($436,560) on July 28, 2026; holds 34,000 after (Direct).
  • Option exercise/conversion: disposed of 51,000 Restricted Stock Units on July 28, 2026 (Direct).

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.

Insider Transactions

Wagner M. Zago — Officer (Chief Scientific Officer)

DateTransactionSecuritySharesPriceValueHeld After
2026-07-28Option exercise/conversionOrdinary Shares, par value $0.01 per share51,000——85,000
2026-07-28Disposition to the issuerOrdinary Shares, par value $0.01 per share51,000$9$436.6K34,000
2026-07-28Option exercise/conversionRestricted Stock Units51,000——0

Key Dates

DateDescription
2026-07-28Option exercise/conversion (51,000 shares)
2026-07-28Disposition to the issuer (51,000 shares)
2026-07-28Option exercise/conversion (51,000 shares)

Keywords

insider transaction, Form 4, PRTA, PROTHENA CORP PUBLIC LTD CO, neutral, Wagner M. Zago

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.